Product ID: SQMIG35A2649
Report ID:
SQMIG35A2649 |
Region:
Global |
Published Date: April, 2024
Pages:
157
|
Tables:
66 |
Figures:
75
In recent years, personalized medicine and custom treatments have risen to the fore in medical circles worldwide. The global market for companion diagnostics is expanding rapidly as a result of this trend. Their use of companion diagnostics aimed at identifying specific biomarkers or genetic variations to guide the selection of appropriate therapies is targeted toward improving medical treatment for individual patients. With the rise of precision medicine, however, companion diagnostics are being produced in tandem with therapeutic drugs by pharmaceutical companies entering into partnerships and alliances with diagnostic firms. The makers of drugs and diagnostic tests are actively engaged in strategic alliances, mergers & acquisitions, and technological milestones to position themselves for the market in companion diagnostics. And they do not want to lose out on opportunities created by changing customer demands that go with a revolution toward person-centered health care.
Top Player’s Company Profile
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONGlobal Companion Diagnostics Market size was valued at USD 5.57 billion in 2019 and is poised to grow from USD 6.27 billion in 2023 to USD 16.08 billion by 2031, growing at a CAGR of 12.5% in the forecast period (2024-2031).
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Product ID: SQMIG35A2649